(Q48515376)

12 February 2018

title

Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. (English)

1 reference

12 February 2018

1 reference

Deok Hee Lee

1

1 reference

12 February 2018

Kwang Deog Jo

2

1 reference

12 February 2018

Hyeon Gak Kim

3

1 reference

12 February 2018

Soo-Jung Choi

4

1 reference

12 February 2018

Seung Mun Jung

5

1 reference

12 February 2018

Dae Sik Ryu

6

1 reference

12 February 2018

Man Soo Park

7

1 reference

12 February 2018

publication date

1 August 2002

1 reference

12 February 2018

Journal of Vascular and Interventional Radiology

published in

1 reference

12 February 2018

volume

13

1 reference

12 February 2018

issue

8

1 reference

12 February 2018

page(s)

769-774

1 reference

12 February 2018

Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Acute stroke intervention with intraarterial urokinase infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Local intra-arterial thrombolysis in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Acceleration of thrombolysis with ultrasound through the cranium in a flow model

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Safety and efficacy of abciximab use in conjunction with intracoronary urokinase in patients requiring angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961984-8

7 January 2021

10.1016/S1051-0443(07)61984-8

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

12171979

1 reference

12 February 2018